News
Of ‘miracles’ and money: Why hemophilia drugs are so expensive
The U.S. hemophilia drug market, which serves about 20,000 patients, is worth $4.6 billion a year.
News
Sickle cell patients suffer discrimination, poor care – and shorter lives
Sickle cell disease is “a microcosm of how issues of race, ethnicity and identity come into conflict with issues of health care.”
News
Medicare yet to save money through ACO model
A high-profile Medicare experiment pushing doctors and hospitals to join together to operate more efficiently has yet to save the government money...